Nuveen
SNPS icon

Nuveen’s Synopsys SNPS Stock Holding History

Nuveen’s Portfolio SNPS Stock Details SNPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,300
Closed -$3K – 3264
2022
Q3 		$3K Buy
+11,300
New +$3.83M ﹤0.01% 3252

Other funds holding SNPS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NC
Nvidia Corp Santa Clara, California $63.4B AUM 136.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Nuveen's SNPS Position: Q2 2026 in Review

Nuveen reduced its Synopsys (SNPS) stake by 51% in Q2 2026, selling an estimated $343M and leaving 687,773 shares worth $307M. The position accounts for 0.07% of the portfolio, ranked #198.

Nuveen first reported a position in SNPS in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.29B in Q4 2023. 1,450 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Nuveen held 687,773 shares of Synopsys worth $307M as of Q2 2026.
  • Nuveen sold 729,600 Synopsys shares in Q2 2026, an estimated $343M.
  • Synopsys made up 0.07% of Nuveen's portfolio in Q2 2026, its #198 holding.
  • Nuveen first reported a position in Synopsys in Q2 2013 and has held it in 53 quarters since.
  • Nuveen's Synopsys position peaked at $1.29B in Q4 2023.
  • 1,450 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.